Posted in | News | Medical Robotics

AI-Powered Medical Imaging Automatically Analyzes Knee X-rays for Osteoarthritis

In the United States, 23% of all adults—over 54 million people—have arthritis and x-rays are often used to diagnose these patients. With this partnership Radiobotics will provide its FDA-cleared technology, RBknee™ for users of the TeleRay platform to automatically analyse knee x-rays for signs of osteoarthritis.

Tim Kelley, TeleRay CEO believes that Artificial Intelligence is the perfect addition to their existing service delivery and allows TeleRay to provide even more value to the customers they already serve. "We are always looking for innovative ways to serve our customers' needs and we see an increasing demand for AI in Radiology. Our world-leading platform is now AI-enabled and having products like RBknee™ unlocked for our customers is central to the TeleRay vision."

Existing TeleRay customers can access this product today on the TeleRay platform in a few clicks. This seamless integration is key to creating a significant impact for customers using RBknee™. Mads Jarner Brevadt, Radiobotics CEO believes that this partnership is key to allowing more clinicians across the US to get access to Radiobotics' knee osteoarthritis tool. "It's a pleasure to work with the team at TeleRay, we see first hand the value they deliver for clinicians each day. Trusted partnerships like this are key for us at Radiobotics, to allow the technology which we have built to be in the hands of clinicians across the US."

​​​​​​​Lowering healthcare cost is a primary mission of Radiobotics and TeleRay. TeleRay enables Radiobotics AI to a broader market and reach to those who normally would not be able to use these kinds of advanced applications for diagnosis. As TeleRay CTO Cody Neville states- "Access to AI in remote and rural areas is unheard of. Although we are networked with 80% of top 100 hospitals in the US, we expect to reach and help the professionals and patients who normally wouldn't have this benefit at such a low cost."

He continued "Lowering healthcare cost and serving those in massively underserved markets is our focus." He spoke further about TeleRay's mission to grow a global healthcare communications network that meets the needs of all patients, clinicians and providers with AI and other developments including musculoskeletal radiology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.